MYND Life Sciences Inc. (MYNDF)

USD 0.06

(0.0%)

Revenue Summary of MYND Life Sciences Inc.

  • MYND Life Sciences Inc.'s latest annual revenue in 2023 was 92.99 Thousand CAD , down 0.0% from previous year.
  • MYND Life Sciences Inc.'s latest quarterly revenue in 2024 Q2 was - CAD , down -100.0% from previous quarter.
  • MYND Life Sciences Inc. reported a annual revenue of - CAD in annual revenue 2022, down 0.0% from previous year.
  • MYND Life Sciences Inc. reported a annual revenue of - CAD in annual revenue 2021, down 0.0% from previous year.
  • MYND Life Sciences Inc. reported a quarterly revenue of - CAD for 2024 Q2, down -100.0% from previous quarter.
  • MYND Life Sciences Inc. reported a quarterly revenue of 1.00 CAD for 2024 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of MYND Life Sciences Inc. (2023 - 2019)

Historical Annual Revenue of MYND Life Sciences Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 92.99 Thousand CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%

Peer Revenue Comparison of MYND Life Sciences Inc.

Name Revenue Revenue Difference
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.41%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -427.723%
SQZ Biotechnologies Company 21.47 Million USD 99.567%
Evofem Biosciences, Inc. 18.21 Million USD 99.49%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.924%
Mesoblast Limited 5.9 Million USD 98.424%
Propanc Biopharma, Inc. - USD -Infinity%
Genus plc 668.8 Million USD 99.986%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 77.329%
Marizyme, Inc. 645.81 Thousand USD 85.601%
ContraFect Corporation - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -21.142%
Intellipharmaceutics International Inc. 65.72 Thousand USD -41.477%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -135.31%
MultiCell Technologies, Inc. 49.32 USD -188444.201%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.813%
EV Biologics, Inc. 48.9 Thousand USD -90.164%
Q BioMed Inc. 284.35 Thousand USD 67.298%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.686%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.962%
Oncotelic Therapeutics, Inc. 70 Thousand USD -32.843%
Skye Bioscience, Inc. - USD -Infinity%
Therapeutic Solutions International, Inc. 98.99 Thousand USD 6.065%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -22.801%
IMV Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 85.879%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.999%
Halberd Corporation 999.00 USD -9208.308%
Enzolytics Inc. 52.79 Thousand USD -76.131%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 93.207%
SYBLEU INC 11.69 Thousand USD -695.058%
Nuo Therapeutics, Inc. 608.52 Thousand USD 84.719%
argenx SE 1.22 Billion USD 99.992%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 95.187%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 84.938%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.989%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.936%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 83.326%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 90.68%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.808%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 99.443%
ONE Bio Corp. 52.29 Million USD 99.822%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 60.691%
Regen BioPharma, Inc. 236.56 Thousand USD 60.691%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 33.693%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 80.371%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 98.806%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -615.308%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -135.215%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 97.208%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 98.605%
IntelGenx Technologies Corp. 1.03 Million USD 91.05%
Gelesis Holdings, Inc. 25.76 Million USD 99.639%
CSL Limited 14.8 Billion USD 99.999%
Cellectis S.A. 755 Thousand USD 87.683%